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Abstract 
Background: Exercise testing is a diagnostic tool for evaluating the induction of stress-induced 
paroxysmal atrial fibrillation (PAF). Resting P-wave dispersion has been suggested to be greater in 
males versus females but if used by clinicians, gender difference in response to exercise must be 
determined. Methods: Sixteen healthy subjects (n=8 male, age: 21±0.3; n=8 female, age: 23±1.4) 
performed an incremental exercise test using the Bruce protocol. Electrocardiograms were recorded at 
rest, end-exercise, 1, 3, and 5 mins recovery. P-waves were measured in each lead with the maximum 
(P-max) and minimum (P-min) P-wave durations and dispersion calculated. Results: There was a 
significant decrease in P-max from rest to end-exercise in males and females [males, 118.3±7.4 
(95%CI: 109.7 to 126.8ms) vs. 97.9±6.2 (89.3 to 106.4ms); females, 109.4±4.5 (100.8 to 117.9ms) vs. 
94.3±4.6 (85.7 to 102.8ms); p=0.001 (5.7 to 29.8ms)]. Similarly, for P-min [males, 65.6±5.6 (57.4 to 
73.9ms) vs. 50.8±2.7 (42.5 to 59.0ms); females, 58.4±3.3 (50.1 to 66.6ms) vs. 45.6±2.7 (37.4 to 
53.9ms); p=0.01 (2.2 to 25.4ms)]. Irrespective of gender there was limited change in P-wave 
dispersion in response to exercise.  Males had a longer P-max versus females during the protocol 
[109.6±2.3 (105.8 to 113.4ms) vs. 103.6±1.8 (99.8 to 107.4ms); p=0.03] but this was not stage-
specific. There was no gender differences in either P-min (p=0.12) or P-wave dispersion (p=0.64) 
across the protocol or stage-specific. Conclusions: Results from this study indicate that in contrast to 
P-max and P-min, the P-wave dispersion may not be significantly influenced by the sympathetic 
nervous system in males and females. Therefore, this study suggests males and females should be 
evaluated in the same way using the P-wave dispersion for predicting the development of stress-
induced PAF at rest and during exercise testing protocols.  
Key words: P-wave dispersion; Paroxysmal atrial fibrillation; Exercise; Gender 
Author Biographies 
Ashton Faulkner MSc, BSc (Hons) 
Ashton Faulkner is a PhD candidate at the Royal Veterinary College, University of London, UK and is 
studying the role of PPARβ/δ signalling on endothelial cell metabolism and its impact on angiogenesis. 
He has an MSc in stem cells and regenerative medicine from the University of Bristol, UK.  He 
graduated with a BSc (Hons) degree in Physiology from the University of Hertfordshire, UK.  His 
research interests are cardiovascular physiology and disease, the potential of regenerative medicine 
and the influence that exercise, ageing and diabetes may have on these factors. 
Dr Andrew Garrett (PhD Exercise Science), MSc, BA (Hons), PG Cert 
Dr Andrew Garrett is based with the Exercise, Health and Human Performance Research Group, in 
the Department of Sport, Health and Exercise Science at the University of Hull, UK.  His doctoral work 
at the University of Otago in New Zealand investigated fluid balance control and thermoregulation. His 
main areas of expertise are the markers of fatigue in temperature regulation and hypoxic stress. He 
has an interest in the limitations and control of homeostasis in chronic disease. 
 
 
 
 
 
 
 
Introduction 
Atrial fibrillation (AF) is the most common arrhythmia observed in the clinical arena 1 and the athletic 
community2. It has been suggested that the overall risk of AF is significantly higher in athletes than for 
non-athletes and more predominant in males 1, 3. The pathological mechanisms of AF have not been 
fully elucidated. One factor possibly contributing to its initiation is stress, both physiological and 
psychological, due to fluctuations in autonomic nervous system activity 4-6. This form of AF is often 
paroxysmal in nature (self-terminating episodes that generally last 7 days or less, most often less than 
24 hours) 7 and can be present in the absence of co-morbidities such as obesity, hypertension and 
cardiovascular disease. 
The cheapest and most detailed diagnostic tool for examining the electrical activity of the heart is the 
electrocardiogram (ECG). A relatively new ECG measurement termed the P-wave dispersion has 
been shown to be greater in patients with a history of paroxysmal atrial fibrillation (PAF) compared 
with healthy controls and has been proposed to be a much more sensitive and specific marker for 
predicting the development of PAF 8-10 compared to the P-wave duration. Indeed, a retrospective study 
of 42,751 patients showed that those who subsequently went on to develop AF had significantly 
greater P-wave dispersions compared with those who did not 11. 
The P-wave dispersion has been suggested to be greater in young physically active (moderate 
endurance trained) males compared with females under resting conditions 12. However this 
relationship has not been demonstrated during exercise. The clinical exercise test is routinely applied 
in the clinical arena for assessing the induction of stress-induced PAF 7 and may be a useful tool in 
cardiac screening for athletes. It is therefore important to establish the P-wave dispersion response to 
exercise and highlight any gender differences that may exist. Therefore, the aim of this study is to 
identify changes in P-wave indices in response to exercise with a particular focus on the P-wave 
dispersion and to highlight any gender differences that may exist. 
Methods 
Subjects 
Sixteen healthy participants (n=8 male, age: 21±0.3; n=8 female, age: 23±1.4) were recruited for the 
study. All participants were healthy at the time of participation and had no history of cardiovascular 
disease. All participants completed a health screen immediately prior to exercise and gave written 
informed consent. Exclusion criteria for this study included any person with known cardiovascular 
conditions, anyone who was outside of the age range 18-40 years and anyone who could not give 
written informed consent.  This study had received ethical approval from the University of 
Hertfordshire, School of Life Sciences Research Ethics committee that complies with international 
standards according to the Helsinki Declaration (revised 2008).  
Exercise Protocol 
Participants were allowed to rest for five minutes before a resting ECG was recorded. Participants 
followed the clinically used Bruce protocol13 which consisted of seven three minute stages of differing 
speed and incline (Table 1), lasting a maximum of 21 minutes. In common with previous research 
methods, the ECG was analysed at rest, at end exercise, and at 1, 3, and 5 minutes into recovery 9. 
The ECG was continually recorded and monitored throughout the protocol. In addition to ECG indices, 
all participants had their age, gender, maximum exercise time, resting and maximum heart rate, and 
number of MET’s recorded. Cessation of exercise was either due to completion of the protocol or at 
the participants’ request. 
Electrocardiogram (ECG) 
All 12-lead ECG’s were performed adopting the Mason-Liker lead arrangement as per standard 
clinical practice8. ECG’s were recorded at a speed of 25mm/s and with a voltage gain of 10mm/mV. 
The P-wave was measured in each lead across one cardiac cycle and the minimum and maximum P-
wave duration from the ECG recorded. The P-wave dispersion, defined as the difference between the 
maximum and the minimum P-wave duration 8, was then calculated for each individual from ECG’s 
recorded at rest, end exercise, and 1, 3, and 5 minutes recovery. The P-wave was considered to be 
defined as the distance between the first visible upward departure from the bottom of the baseline to 
the point of return to the bottom of the baseline 10. All ECG’s were analysed by the same observer on 
a computer screen using a cursor in agreement with the work carried out by Dilaveris et al., (1999) 
who demonstrated this to be the method with the lowest intra and inter-observer error 14. 
Statistical Analysis 
All data is expressed as mean±standard error of the mean (SEM) with 95% confidence intervals. The 
effect of gender and exercise on P-wave indices was determined by 2-way ANOVA and Turky post-
hoc test performed using SPSS data analysis software. All other variables were analysed using 
independent t-test. Significance was assumed at P=<0.05. 
Results 
Participant baseline (resting) characteristics are shown in Table 2. There was no significant difference 
in age (21±0.3 vs. 23±1.4; p=0.22), heart rate (83±6 vs. 85±5 bpm; p=0.76), maximum P-wave 
duration [118.3±7.4 (95%CI: 109.7 to 126.8ms) vs. 109.4±4.5 (100.8 to 117.9ms); p=0.32), minimum 
P-wave duration [65.6±5.6 (57.4 to 73.9ms) vs. 58.4±3.3 (50.1 to 66.6ms); p=0.28] or P-wave 
dispersion [52.6±4.4 (43.0 to 62.2ms) vs. 53.5±5.0 (43.9 to 63.1ms); p=0.90] between males and 
females when at rest. 
P-wave characteristics measured at rest, at end exercise, and at 1, 3, and 5 minutes recovery for both 
males and females are shown in Table 3. Despite a trend towards prolonged values in males, at no 
specific stage of the protocol are there any significant differences between males and females with 
regards to the maximum and minimum P-wave durations or the P-wave dispersion (Table 3). 
The maximum and minimum P-wave durations significantly decreased at the end of exercise 
participation in both genders [P-max: males, 118.3±7.4 (109.7 to 126.8ms) vs. 97.9±6.2 (89.3 to 
106.4ms); females, 109.4±4.5 (100.8 to 117.9ms) vs. 94.3±4.6 (85.7 to 102.8ms); p=0.001 (5.7 to 
29.8ms)]; [P-min: males, 65.6±5.6 (57.4,73.9ms) vs. 50.8±2.7 (42.5 to 59.0ms); females, 58.4±3.3 
(50.1 to 66.6ms) vs. 45.6±2.7 (37.4 to 53.9ms); p=0.01 (2.2 to 25.4ms)] (Figures 1 & 2). In males 
(Figure 1) and females (Figure 2) the values returned back towards baseline measurements within the 
5 minute recovery period. When viewed across the whole protocol (Table 4), there was a significant 
difference in maximum P-wave duration between males and females [109.6±2.3 (105.8 to 113.4ms) 
vs. 103.6±1.8 (99.8 to 107.4ms); p=0.03]. However, this difference was not stage specific (Table 3). 
Despite a trend towards males having a longer minimum P-wave duration across the whole protocol 
compared to females (Table 4), this did not reach significance (p=0.12). 
The change in P-wave dispersion at the end of exercise for both males and females is shown in Figure 
3. There was no significant change in P-wave dispersion at the end of exercise participation for either 
gender [males, 52.6±4.4 (43.0 to 62.2ms) vs. 47.1±4.4 (37.5 to 56.7ms); females, 53.5±5.0 (43.9 to 
63.1ms) vs. 48.5±6.0 (38.9 to 58.1ms); p=0.81 (-8.3 to 18.8ms)].  There were no gender differences in 
the P-wave dispersion at any specific protocol stage (Table 3) or across the whole protocol (p=0.64)  
(Table 4). 
The relationship between the three P-wave indices and heart rate is demonstrated in Table 5. The 
maximum and minimum P-wave duration (Table 5) displayed a limited inverse relationship with heart 
rate (p-max, r2=0.24 p=0.00; P-min, r2=0.18 p=0.00), whereas there was no clear relationship between 
the P-wave dispersion and heart rate (r2=0.001 p=0.80). 
Discussion 
This study aimed to identify changes in P-wave indices in response to exercise with a particular focus 
on the P-wave dispersion and sought to highlight any gender differences that may exist. The P-wave 
dispersion is suggested to be a new measurement for identifying those individuals that may be at risk 
of developing paroxysmal atrial fibrillation (PAF) 8 and may therefore be a useful measure within both 
the clinical and sports pre-participation screening environments. 
For both males and females the maximum and minimum P-wave durations significantly decreased at 
the end of exercise participation (Figures 1 & 2 respectively). Limited studies have investigated P-
wave changes in response to exercise in healthy individuals making a direct comparison hard to 
determine. However, these results are in agreement with early studies15 that demonstrated a reduction 
in P-wave duration concomitant to an increase in heart rate as a result of exercise participation in 
healthy individuals.  
As an individual takes part in exercise there is a greater predominance in sympathetic nervous system 
activity and a release of catecholamine’s 16, 17. This has a number of effects. (1) An increase in the rate 
of discharge of pacemaker action potentials from the sino-atrial node (sino-atrial node depolarisation) 
and throughout the rest of the atria18, (2) a faster rate of repolarisation of the sino-atrial node18, and (3) 
an increase in action potential conduction velocity through the cardiac muscle fibres, all of which 
culminating in the elevation of heart rate. It is suggested this physiological response may account for 
the reduced P-wave durations observed in this study. This is further supported by the relationship 
between heart rate and maximum and minimum P-wave duration found in this study (P-max, r2=0.24 
p=0.00; P-min, r2=0.18 p=0.00) (Table 5). Although an inverse relationship existed it was limited, 
suggesting the presence of other influencing factors acting on atrial conduction, such as the size of the 
atria 19. However, a number of more recent studies comparing P-wave indices in healthy controls and 
those with cardiac pathology report no significant reduction in maximum and minimum P-wave 
durations in response to exercise within the healthy control groups 9, 20. Barutcu and colleagues 
studied P-wave indices changes in response to exercise in patients with isolated myocardial bridging 
and healthy controls and reported that for healthy controls there was no significant difference in 
maximum and minimum P-wave duration at rest and at the end of exercise participation (P-max: 
113±9ms vs. 115±8ms; P-min: 68±11ms vs. 68±11ms; p=>0.05). 
The P-wave dispersion (Figure 3) reported no significant change for either gender after exercise 
participation (males, 52.6±4.4 vs. 47.1±4.4ms; females, 53.5±5.0 vs. 48.5±6.0 ms; p=0.81) (Figure 3). 
This finding is in agreement with Barutcu et al. (2009) who reported no significant difference in P-wave 
dispersion between rest and exercise in their healthy control group (45±11 vs. 48±15ms; p=>0.05) 20. 
Additionally, the P-wave dispersion in the current study observed a limited relationship with heart rate 
(r2=0.001 p=0.80) (Table 5) suggesting that the P-wave dispersion, in contrast with the P-wave 
duration, is relatively unaffected by changes in sympathetic nervous activity. If the P-wave dispersion 
is shown to be more than or just as sensitive as the P-wave duration then the requirement for exercise 
testing for assessing PAF risk could be removed, making patient assessment less time consuming 
and thus a more useful tool for the clinician. More research into the sensitivity of the P-wave 
dispersion and larger trials are thus warranted. 
More importantly, in the whole protocol, males had a significantly longer maximum P-wave duration 
compared with females (p=0.03) (Table 4) but this difference could not be seen at any specific stage 
of the protocol (Table 3). Limited research using exercise has been conducted in determining gender 
differences in P-wave indices. For example, a previous study by Yildiz and colleagues (2008) studied 
P-wave duration and related factors in endurance trained students.  They determined that males had a 
significantly longer maximum P-wave duration compared with females when in a resting state 
(112.79±16.07 vs. 109.86±12.70ms, p=0.02) 12. However, this study did not investigate if this finding 
continued in response to exercise. Therefore, the current study demonstrates that despite a trend 
towards prolonged values in males, there is no significant difference in maximum P-wave duration at 
the end of participation of exercise between males and females (p=0.65) (Table 3). 
There was no gender difference in the whole protocol with minimum P-wave duration (p=0.12) or P-
wave dispersion (p=0.64) (Table 4), or at any specific stage of the protocol (Table 3). These results 
differ from the work of Yildiz et al. (2008) who reported a significant difference between males and 
females at rest for minimum P-wave duration (54.17±12.88 vs. 57.17±11.39ms; p=0.005) and P-wave 
dispersion (58.56±16.24 vs. 52.76±12.57ms) respectively 12. However, Yildiz and colleagues (2008) 
did not investigate these characteristics beyond resting conditions.  Therefore, the results of the 
current study (Table 3 & 4) indicate that there are no significant differences in minimum P-wave 
duration and P-wave dispersion between males and females after the participation of exercise. 
However, the trend towards prolonged P-wave duration observed in this study and the statistically 
significant difference reported by Yildiz et al. (2008) may support the suggestion that females may 
have a more dominant parasympathetic influence on heart rate control 21 but this requires further 
investigation. 
There were a number of limitations that may have influenced the results of the current study. Firstly, it 
has been shown that the size of the left atrium can alter the duration and dispersion of the P-wave in 
healthy individuals 19. However, due to no echocardiography equipment being available, atrial size 
could not be determined in this study. Additionally, it is well documented that increased body mass 
index (BMI) is associated with the development of atrial fibrillation 22 and that subjects with increased 
BMI have increased P-wave dispersion, which can be reduced upon decreasing body weight 23. As 
BMI and atrial size was not taken into account in this study it cannot be confirmed that no additional 
influences on P-wave duration and dispersion was taking place. Secondly, it is suggested that a 
limitation of the present work is the relatively small sample size.  However, this often reflects the time 
taken for exercise stress tests in a study of this nature. 
In conclusion, this study indicates that the P-wave response after exercise participation is similar for 
both males and females, suggesting that changes in atrial conduction in response to exercise are the 
same for both genders. It may indicate that the P-wave dispersion, unlike the P-wave duration, may 
not be significantly influenced by changes in sympathetic activity. In addition, there is no significant 
difference in P-wave duration or dispersion between males and females at rest or after participation in 
the incremental exercise test. This indicates that both males and females should be evaluated in the 
same way using P-wave dispersion in predicting the development of stress-induced paroxysmal atrial 
fibrillation during clinical exercise testing. Further studies with greater sample sizes are clearly 
warranted to further the results of this study and to identify ‘normal’ and ‘abnormal’ reference ranges, 
in terms of P-wave dispersion values during and after exercise. Furthermore, it is suggested that, 
future work should investigate other factors that affect cardiovascular risk, such as age and ethnicity 
and how they may influence P-wave indices. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1: Timings and intervals of the full Bruce protocol 
Stage Speed (km/h) Gradient (%) Time (min) 
1 2.7 10 3 
2 4.0 12 3 
3 5.5 14 3 
4 6.6 16 3 
5 8.0 18 3 
6 8.9 20 3 
7 9.7 22 3 
kilometers per hour (km/h); minutes (min) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Participants baseline characteristics 
 Male Subjects 
(n = 8) 
Female Subjects 
(n = 8) 
p value 
Age 21 ± 0.3 23 ± 1.4 0.22 
Heart rate (beats/min) 83 ± 6 85 ± 5 0.76 
P-Max wave duration (ms) 118.3 ± 7.4 109.4 ± 4.5 0.32 
P-Min wave duration (ms) 65.6 ± 5.6 58.4 ± 3.3 0.28 
P-wave dispersion (ms) 52.6 ± 4.4 53.5 ± 5.0 0.90 
beats per minute (beats/min); milliseconds (ms); significance assumed if p<0.05 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3: Male and female P-wave indices at each stage of the protocol (mean±SEM) 
 
Male Subjects 
n= 8 
Female Subjects 
n= 8 
p value 
Exercise Duration 13.0 ± 0.8  11.1 ± 0.7 0.12 
MET Value 14.9 ± 0.4 14.0 ± 0.2 0.08 
Rest    
    Heart rate (beats/min) 83 ± 6 85 ± 5 0.76 
    P-max wave duration (ms) 118.3±7.4  109.4 ± 4.5 0.32 
    P-min wave duration (ms) 65.6 ± 5.6 58.4 ± 3.3 0.28 
    P-wave dispersion (ms) 52.6 ± 4.4 53.5 ± 5.0 0.90 
End Exercise    
    Heart rate (beats/min) 176 ± 2 177 ± 4 0.71 
    P-max wave duration (ms) 97.9 ± 6.2 94.3 ± 4.6 0.65 
    P-min wave duration (ms) 50.8 ± 4.5 45.6 ± 2.7 0.35 
    P-wave dispersion (ms) 47.1 ± 4.4 48.5 ± 6.0 0.86 
1 Minute Recovery    
    Heart rate (beats/min) 139 ± 6 141 ± 6 0.77 
    P-max wave duration (ms) 106.1 ± 3.1 100.5 ± 1.6 0.13 
    P-min wave duration (ms) 65.0 ± 3.5 61.5 ± 2.7 0.44 
    P-wave dispersion (ms) 41.1 ± 3.5 39.0 ± 4.0 0.69 
3 Minute Recovery    
    Heart rate (beats/min) 115 ± 5 116 ± 5 0.93 
    P-max wave duration (ms) 112.3 ± 2.8 106.0 ± 2.1 0.09 
    P-min wave duration (ms) 69.1 ± 4.3 66.3 ± 4.8 0.66 
    P-wave dispersion (ms) 43.3 ± 4.7 39.8 ± 4.8 0.61 
5 Minute Recovery    
    Heart rate (beats/min) 105 ± 5 107 ± 4 0.83 
    P-max wave duration (ms) 113.4 ± 2.4 107.9 ± 4.4 0.29 
    P-min wave duration (ms) 65.8 ± 4.2 64.1 ± 4.9 0.80 
    P-wave dispersion (ms) 47.6 ± 3.0 43.8 ± 7.2 0.63 
Minutes (min); beats per minute (beats/min); milliseconds (ms); Significance assumed if p<0.05 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4: Male and female P-wave indices across the whole protocol (Mean±SEM; 95%CI) 
P-wave Indie Male 
(n=8) 
Female 
(n=8) 
p-value 
P-Max (ms) 109.6 ± 2.3  (105.8 to 113.4) 103.6 ± 1.8 (99.8 to 107.4) 0.03 
P-Min (ms) 63.3 ± 2.1 (59.6 to 66.9) 59.2 ± 2.0 (55.5 to 62.9) 0.12 
P-Disp (ms) 46.4 ± 1.8 (42.0 to 50.7) 44.9 ± 2.5 (40.6 to 49.2) 0.64 
Milliseconds (ms); Significance assumed if p<0.05 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5: Relationship of P-wave indices and heart rate. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
P-wave Indie r r
2
 p-value 
P-Max duration - 0.49 0.24 0.00 
P-Min duration - 0.42 0.18 0.00 
P-wave dispersion - 0.03 0.00 0.80 
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